BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32473977)

  • 1. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
    Dinka H; Milkesa A
    Infect Genet Evol; 2020 Oct; 84():104386. PubMed ID: 32473977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corona virus versus existence of human on the earth: A computational and biophysical approach.
    Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A
    Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico analysis of the promoter region of olfactory receptors in cattle (
    Samuel B; Dinka H
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(6):853-865. PubMed ID: 32028828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
    Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
    J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study.
    Liu B; Liu K; Zhang H; Zhang L; Bian Y; Huang L
    J Med Internet Res; 2020 Oct; 22(10):e22299. PubMed ID: 32931441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of codon usage pattern in SARS-CoV-2.
    Hou W
    Virol J; 2020 Sep; 17(1):138. PubMed ID: 32928234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.
    Benvenuto D; Angeletti S; Giovanetti M; Bianchi M; Pascarella S; Cauda R; Ciccozzi M; Cassone A
    J Infect; 2020 Jul; 81(1):e24-e27. PubMed ID: 32283146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Expansion of a Novel SARS-CoV-2 Mutant.
    Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline.
    Kuchinski KS; Jassem AN; Prystajecky NA
    J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
    Nelson CW; Ardern Z; Goldberg TL; Meng C; Kuo CH; Ludwig C; Kolokotronis SO; Wei X
    Elife; 2020 Oct; 9():. PubMed ID: 33001029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
    Srivastava R; Daulatabad SV; Srivastava M; Janga SC
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses.
    Cagliani R; Forni D; Clerici M; Sironi M
    Infect Genet Evol; 2020 Sep; 83():104353. PubMed ID: 32387562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
    Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
    Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin and underlying driving forces of the SARS-CoV-2 outbreak.
    Chaw SM; Tai JH; Chen SL; Hsieh CH; Chang SY; Yeh SH; Yang WS; Chen PJ; Wang HY
    J Biomed Sci; 2020 Jun; 27(1):73. PubMed ID: 32507105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
    Mukherjee M; Goswami S
    PLoS One; 2020; 15(8):e0237559. PubMed ID: 32780783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.